Inventor · disambiguated record
Eric Borges
Also filed as: BORGES ERIC
24 granted patents·29 pending applications·389 citations·filing 2003–2025
96Inventor score
Top patents by PatentIndex Score
53 records- 0198US9340621B2Binding molecules for BCMA and CD3AMGEN RES MUNICH GMBH·Filed 2012·Granted May 17, 2016·91 cites·15 claims
- 0297US9150664B2Binding molecules for BCMA and CD3AMGEN RES MUNICH GMBH·Filed 2012·Granted Oct 6, 2015·64 cites·15 claims
- 0396US7705130B2Antibodies directed to HER-3 and uses thereofU3 PHARMA GMBH·Filed 2007·Granted Apr 27, 2010·84 cites·29 claims
- 0494US9598500B2Binding molecules for BCMA and CD3AMGEN RES MUNICH GMBH·Filed 2012·Granted Mar 21, 2017·22 cites·15 claims
- 0592US10766969B2Binding molecules for BCMA and CD3AMGEN RES MUNICH GMBH·Filed 2012·Granted Sep 8, 2020·8 cites·29 claims
- 0691US8318159B2Anti-IGF antibodiesADAM PAUL·Filed 2009·Granted Nov 27, 2012·14 cites·13 claims
- 0790US12281176B2Binding molecules for BCMA and CD3AMGEN INC·Filed 2021·Granted Apr 22, 2025·1 cites·7 claims
- 0890US10752694B2Binding molecules for BCMA and CD3AMGEN RES MUNICH GMBH·Filed 2014·Granted Aug 25, 2020·11 cites·15 claims
- 0989US7498416B2Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereofFIBRON LTD·Filed 2003·Granted Mar 3, 2009·52 cites·6 claims
- 1088US9078879B2Anti CD37 antibodiesBOEHRINGER INGELHEIM INT·Filed 2013·Granted Jul 14, 2015·7 cites·29 claims
- 1186US9550833B2CD33 binding agentsBOEHRINGER INGELHEIM INT·Filed 2015·Granted Jan 24, 2017·5 cites·12 claims
- 1286US8828385B2Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereofYAYON AVNER·Filed 2009·Granted Sep 9, 2014·9 cites·8 claims
- 1385US8771695B2Antibodies directed to HER-3 and uses thereofROTHE MIKE·Filed 2010·Granted Jul 8, 2014·8 cites·20 claims
- 1485US2024141030A1Vegf-binding moleculesBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 1583US9079958B2CD33 binding agentsKONOPITZKY RENATE·Filed 2011·Granted Jul 14, 2015·8 cites·31 claims
- 1682US2023203146A1Ang2-binding moleculesBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 1781US2022251243A1Binding molecules for bcma and cd3AMGEN INC·Filed 2022·Application pending·0 cites
- 1879US2022363744A1Vegf-binding moleculesBOEHRINGER INGELHEIM INT·Filed 2022·Application pending·0 cites
- 1979US2023059353A1Antibodies directed to her-3 and uses thereofDAIICHI SANKYO EUROPE GMBH·Filed 2022·Application pending·0 cites
- 2078US9249230B2Antibodies directed to HER-3 and uses thereofROTHE MIKE·Filed 2009·Granted Feb 2, 2016·2 cites·62 claims
- 2178US2025346684A1Binding molecules for bcma and cd3AMGEN INC·Filed 2025·Application pending·0 cites
- 2276US12281175B2Binding molecules for BCMA and CD3AMGEN INC·Filed 2020·Granted Apr 22, 2025·0 cites·16 claims
- 2375US10202451B2CD33 binding agentsBOEHRINGER INGELHEIM INT·Filed 2016·Granted Feb 12, 2019·1 cites·12 claims
- 2473US9932399B2Anti CD37 antibodiesBOEHRINGER INGELHEIM INT·Filed 2015·Granted Apr 3, 2018·1 cites·10 claims
- 2572US10179810B2Anti-IGF antibodiesADAM PAUL·Filed 2014·Granted Jan 15, 2019·1 cites·18 claims
- 2672US2021230271A1Anti-cd37 antibodiesBOEHRINGER INGELHEIM INT·Filed 2020·Application pending·0 cites
- 2771US11299538B2Anti-IGF antibodiesBOEHRINGER INGELHEIM INT·Filed 2018·Granted Apr 12, 2022·0 cites·18 claims
- 2870US11267900B2Antibodies directed to HER-3 and uses thereofDAIICHI SANKYO EUROPE GMBH·Filed 2018·Granted Mar 8, 2022·0 cites·12 claims
- 2970US2020308267A1Vegf-binding moleculesBOEHRINGER INGELHEIM INT·Filed 2020·Application pending·0 cites
- 3069US2020207845A1Ang2-binding moleculesBOEHRINGER INGELHEIM INT·Filed 2020·Application pending·0 cites
- 3168US2025136720A1Bispecific and tetravalent cd137 and fap molecules for the treatment of cancerBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 3266US2010189722A1Anti cd37 antibodiesBOEHRINGER INGELHEIM INT·Filed 2008·Application pending·0 cites
- 3364US2018186876A1Anti cd37 antibodiesBOEHRINGER INGELHEIM INT·Filed 2018·Application pending·0 cites
- 3461US2018201671A1Vegf-binding moleculesBOEHRINGER INGELHEIM INT·Filed 2017·Application pending·0 cites
- 3561US2019135907A1Ang2-binding moleculesBOEHRINGER INGELHEIM INT·Filed 2018·Application pending·0 cites
- 3660US2019256593A1Cd33 binding agentsBOEHRINGER INGELHEIM INT·Filed 2018·Application pending·0 cites
- 3759US10100124B2Antibodies directed to HER-3 and uses thereofAMGEN INC·Filed 2015·Granted Oct 16, 2018·0 cites·18 claims
- 3858US2013259859A1Ang2-binding moleculesOTT RENE GEORG·Filed 2013·Application pending·0 cites
- 3958US2013230541A1Anti-igf antibodiesBOEHRINGER INGELHEIM INT·Filed 2012·Application pending·0 cites
- 4057US12146000B2Bispecific and tetravalent CD137 and FAP molecules for the treatment of cancerBOEHRINGER INGELHEIM INT·Filed 2021·Granted Nov 19, 2024·0 cites·48 claims
- 4157US8828382B2Heparin-binding epidermal growth factor-like growth factor binding proteinsROTHE MIKE·Filed 2008·Granted Sep 9, 2014·0 cites·10 claims
- 4257US2014193433A1Bcma-based stratification and therapy for multiple myeloma patientsBORGES ERIC·Filed 2014·Application pending·0 cites
- 4357US2017107281A1Ang2-binding moleculesBOEHRINGER INGELHEIM INT·Filed 2016·Application pending·0 cites
- 4456US2011165153A1Anti cd37 antibodiesBOEHRINGER INGELHEIM INT·Filed 2010·Application pending·0 cites
- 4555US2016200806A1Vegf-binding moleculesBOEHRINGER INGELHEIM INT·Filed 2015·Application pending·0 cites
- 4653US2013101599A1Bcma-based stratification and therapy for multiple myeloma patientsBORGES ERIC·Filed 2012·Application pending·0 cites
- 4752US2012225081A1Vegf-binding moleculesGSCHWIND ANDREAS·Filed 2011·Application pending·0 cites
- 4850US2016131655A1Bcma-based stratification and therapy for multiple myeloma patientsBOEHRINGER INGELHEIM INT·Filed 2016·Application pending·0 cites
- 4947US2014120095A1Bispecific binding molecules for anti-angiogenesis therapyBORGES ERIC·Filed 2013·Application pending·0 cites
- 5045US2016009796A9Heparin-Binding Epidermal Growth Factor-like Growth Factor Binding ProteinsU3 PHARMA GMBH·Filed 2014·Application pending·0 cites
Showing the top 50 of 53 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Eric Borges files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →